Poongjeon Pharmacy Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
44
- Stock Symbol
-
298060
- Investments
-
5
- Share Price
-
$1.69
- (As of Friday Closing)
Poongjeon Pharmacy General Information
Description
Poongjeon Pharmacy Co Ltd, formerly SCM Lifescience Co Ltd is engaged in the research and development of medicines, hair care medicines, and stem cell products in South Korea.
Contact Information
Website
www.scmlifescience.comCorporate Office
- 7-7, Gaetbeol-ro, 145beon-gil
- Yeonsu-gu
- Incheon, 21999
- South Korea
Corporate Office
- 7-7, Gaetbeol-ro, 145beon-gil
- Yeonsu-gu
- Incheon, 21999
- South Korea
Poongjeon Pharmacy Stock Performance
As of 20-Nov-2026, Poongjeon Pharmacy’s stock price is $1.69. Its current market cap is $18.3M with 10.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.69 | $1.69 | $1.50 - $4.04 | $18.3M | 10.8M | 12.5K | $0.07 |
Poongjeon Pharmacy Financials Summary
As of 31-Mar-2026, Poongjeon Pharmacy has a trailing 12-month revenue of $27M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 19,451 | 27,903 | 27,439 | 50,426 |
| Revenue | 27,008 | 16,751 | 604 | 532 |
| EBITDA | 1,300 | 1,027 | (8,911) | (17,512) |
| Net Income | (64) | 142 | (9,071) | (18,327) |
| Total Assets | 33,579 | 36,107 | 15,730 | 19,713 |
| Total Debt | 4,386 | 3,842 | 4,730 | 2,963 |
Poongjeon Pharmacy Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Poongjeon Pharmacy Patents
Poongjeon Pharmacy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025236785-A1 | Method for mass-culturing mesenchymal stem cells | Pending | 11-Mar-2024 | ||
| AU-2025237538-A1 | Rapid layer-separation culturing method for mesenchymal stem cells | Pending | 11-Mar-2024 | ||
| WO-2023243934-A1 | Composition for preventing or treating arthritis comprising functionally enhanced stem cells | Inactive | 15-Jun-2022 | ||
| CA-3225620-A1 | Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells | Pending | 01-Jun-2021 | ||
| US-20240277772-A1 | Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells | Pending | 01-Jun-2021 | A61K40/22 |
Poongjeon Pharmacy Signals
Poongjeon Pharmacy Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Poongjeon Pharmacy Investments & Acquisitions (5)
Poongjeon Pharmacy’s most recent deal was a Merger/Acquisition with Dermasimo for . The deal was made on 15-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dermasimo | 15-Sep-2025 | Merger/Acquisition | Internet Retail | ||
| Poongjeon Pharmaceutical | 17-Jun-2025 | Merger/Acquisition | Distributors/Wholesale | ||
| Rocky Mountain (Manufacturing Facilities in Incheon, South Korea) | 27-Mar-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Vita Therapeutics | 23-Jun-2021 | Early Stage VC | Drug Discovery | ||
| Argos Therapeutics | 13-Feb-2019 | Merger/Acquisition | Drug Discovery |
Poongjeon Pharmacy ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Poongjeon Pharmacy Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Argos Therapeutics | Durham, NC | 1997 | |
| Dermasimo | Seoul, South Korea |
Poongjeon Pharmacy FAQs
-
When was Poongjeon Pharmacy founded?
Poongjeon Pharmacy was founded in 2014.
-
Where is Poongjeon Pharmacy headquartered?
Poongjeon Pharmacy is headquartered in Incheon, South Korea.
-
What is the size of Poongjeon Pharmacy?
Poongjeon Pharmacy has 44 total employees.
-
What industry is Poongjeon Pharmacy in?
Poongjeon Pharmacy’s primary industry is Drug Discovery.
-
Is Poongjeon Pharmacy a private or public company?
Poongjeon Pharmacy is a Public company.
-
What is Poongjeon Pharmacy’s stock symbol?
The ticker symbol for Poongjeon Pharmacy is 298060.
-
What is the current stock price of Poongjeon Pharmacy?
As of 20-Nov-2026 the stock price of Poongjeon Pharmacy is $1.69.
-
What is the current market cap of Poongjeon Pharmacy?
The current market capitalization of Poongjeon Pharmacy is $18.3M.
-
What is Poongjeon Pharmacy’s current revenue?
The trailing twelve month revenue for Poongjeon Pharmacy is $27M.
-
What is Poongjeon Pharmacy’s annual earnings per share (EPS)?
Poongjeon Pharmacy’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process